The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Botulinum toxin type a induces direct analgesic effects in chronic neuropathic pain
Abstract
Objective: Botulinum toxin type A (BTX‐A) has been reported to have analgesic effects independent of its action on muscle tone, possibly by acting on neurogenic inflammation. Such a mechanism may be involved in peripheral neuropathic pain. Methods: A possible direct analgesic effect of BTX‐A pain processing was investigated in 29 patients with focal painful neuropathies and mechanical allodynia using a randomized, double‐blind, placebo‐controlled design. Patients received a one‐time intradermal administration of BTX‐A (20–190 units) into the painful area. Outcome measures, evaluated at baseline, then at 4, 12, and 24 weeks, included average spontaneous pain intensity, quantified testing of thermal and mechanical perception and pain, allodynia to brushing (area, intensity), neuropathic symptoms, clinical global impression, and quality of life. Results: BTX‐A treatment, relative to placebo, was associated with persistent effects on spontaneous pain intensity from 2 weeks after the injection to 14 weeks. These effects correlated with the preservation of thermal sensation at baseline ( p < 0.05). BTX also improved allodynia to brush and decreased pain thresholds to cold, without affecting perception thresholds. There were sustained improvements in the proportion of responders (number needed to treat for 50% pain relief: 3.03 at 12 weeks), neuropathic symptoms, and general activity. Most patients reported pain during the injections, but there were no further local or systemic side effects. Interpretation: These results indicate for the first time that BTX‐A may induce direct analgesic effects in patients with chronic neuropathic pain independent of its effects on muscle tone and suggest novel indications for BTX‐A in analgesia. Ann Neurol 2008
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Hospital Anxiety and Depression Scale
Zigmond, A. S., & Snaith, R. P. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb09716.x · Cited by 47,139
Pain assessment: global use of the Brief Pain Inventory.
Cs, C., & Km, R. (1994) · PubMed · Cited by 5,421
Persistent postsurgical pain: risk factors and prevention
Kehlet, H., Jensen, T. S., & Woolf, C. J. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68700-x · Cited by 4,086
Pharmacologic management of neuropathic pain: Evidence-based recommendations
Dworkin, R. H., O’Connor, A. B., Backonja, M., Farrar, J. T., Finnerup, N. B., Jensen, T. S., Kalso, E. A., Loeser, J. D., Miaskowski, C., Nurmikko, T. J., et al. (2007) · Pain · doi:10.1016/j.pain.2007.08.033 · Cited by 2,126
Prevalence of chronic pain with neuropathic characteristics in the general population
Bouhassira, D., Lantéri-Minet, M., Attal, N., Laurent, B., & Touboul, C. (2008) · Pain · doi:10.1016/j.pain.2007.08.013 · Cited by 1,745
Self-citationAlgorithm for neuropathic pain treatment: An evidence based proposal
Finnerup, N. B., Otto, M., McQuay, H. J., Jensen, T. S., & Sindrup, S. H. (2005) · Pain · doi:10.1016/j.pain.2005.08.013 · Cited by 1,330
Development and validation of the Neuropathic Pain Symptom Inventory
Bouhassira, D., Attal, N., Fermanian, J., Alchaar, H., Gautron, M., Masquelier, E., Rostaing, S., Lanteri-Minet, M., Collin, E., Grisart, J., et al. (2004) · Pain · doi:10.1016/j.pain.2003.12.024 · Cited by 1,329
Self-citationTorrance, N., Smith, B. H., Bennett, M. I., & Lee, A. J. (2006) · The Journal of Pain · doi:10.1016/j.jpain.2005.11.008 · Cited by 1,000
EFNS guidelines on pharmacological treatment of neuropathic pain
Attal, N., Cruccu, G., Haanpää, M., Hansson, P., Jensen, T. S., Nurmikko, T., Sampaio, C., Sindrup, S., & Wiffen, P. (2006) · European Journal of Neurology · doi:10.1111/j.1468-1331.2006.01511.x · Cited by 880
Self-citationSV2 Is the Protein Receptor for Botulinum Neurotoxin A
Dong, M., Yeh, F., Tepp, W. H., Dean, C., Johnson, E. A., Janz, R., & Chapman, E. R. (2006) · Science · doi:10.1126/science.1123654 · Cited by 770
Subcutaneous administration of botulinum toxin A reduces formalin-induced pain
Cui, M., Khanijou, S., Rubino, J., & Aoki, K. R. (2004) · Pain · doi:10.1016/j.pain.2003.10.008 · Cited by 676
The impact of neuropathic pain on health-related quality of life: Review and implications
Jensen, M. P., Chodroff, M. J., & Dworkin, R. H. (2007) · Neurology · doi:10.1212/01.wnl.0000259085.61898.9e · Cited by 575
Brashear, A., Gordon, M. F., Elovic, E. P., Kassicieh, V. D., Marciniak, C. M., Do, M., Lee, C.-H., JENKINS, S. W., & Turkel, C. C. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011892 · Cited by 565
Postherpetic Neuralgia: Irritable Nociceptors and Deafferentation
Fields, H. L., Rowbotham, M., & Baron, R. (1998) · Neurobiology of Disease · doi:10.1006/nbdi.1998.0204 · Cited by 561
Regulated Exocytosis Contributes to Protein Kinase C Potentiation of Vanilloid Receptor Activity
Morenilla-Palao, C., Planells-Cases, R., García-Sanz, N., & Ferrer-Montiel, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311515200 · Cited by 425
Analgesic Therapy in Postherpetic Neuralgia: A Quantitative Systematic Review
Hempenstall, K., Nurmikko, T. J., Johnson, R. W., A'Hern, R. P., & Rice, A. S. C. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020164 · Cited by 400
Epidemiology and treatment of neuropathic pain: The UK primary care perspective
Hall, G. C., Carroll, D., Parry, D., & McQuay, H. J. (2006) · Pain · doi:10.1016/j.pain.2006.01.030 · Cited by 379
Smith, B. H., Torrance, N., Bennett, M. I., & Lee, A. J. (2007) · The Clinical Journal of Pain · doi:10.1097/01.ajp.0000210956.31997.89 · Cited by 303
Mechanisms of central neuropathic pain: a combined psychophysical and fMRI study in syringomyelia
Ducreux, D., Attal, N., Parker, F., & Bouhassira, D. (2006) · Brain · doi:10.1093/brain/awl016 · Cited by 258
Self-citationCHRONIC HYPERALGESIA AND SKIN WARMING CAUSED BY SENSITIZED C NOCICEPTORS
CLINE, M. A., OCHOA, J., & TOREBJÖRK, H. E. (1989) · Brain · doi:10.1093/brain/112.3.621 · Cited by 250
Systemic lidocaine in pain due to peripheral nerve injury and predictors of response
Attal, N., Rouaud, J., Brasseur, L., Chauvin, M., & Bouhassira, D. (2004) · Neurology · doi:10.1212/01.wnl.0000103237.62009.77 · Cited by 194
Self-citationMechanisms of pain in peripheral neuropathy
Attal, N., & Bouhassira, D. (1999) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1999.tb07386.x · Cited by 161
Self-citationA Focused Review on the Use of Botulinum Toxins for Neuropathic Pain
Argoff, C. E. (2002) · The Clinical Journal of Pain · doi:10.1097/00002508-200211001-00010 · Cited by 158
Capsaicin evoked pain and allodynia in post-herpetic neuralgia
Petersen, K. L., Fields, H. L., Brennum, J., Sandroni, P., & Rowbotham, M. C. (2000) · Pain · doi:10.1016/s0304-3959(00)00311-0 · Cited by 152
A randomized, double-blind, placebo-controlled trial of a glycine antagonist in neuropathic pain
Wallace, M. S., Rowbotham, M. C., Katz, N., Dworkin, R. H., Dotson, R. M., Galer, B. S., Rauck, R. L., Backonja, M. M., Quessy, S. N., & Meisner, P. D. (2002) · Neurology · doi:10.1212/01.wnl.0000036273.98213.34 · Cited by 125
Anti-allodynic efficacy of botulinum neurotoxin A in a model of neuropathic pain
Luvisetto, S., Marinelli, S., Cobianchi, S., & Pavone, F. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2006.12.004 · Cited by 100
A randomized, double-blind, placebo controlled study on analgesic effects of botulinum toxin A
Voller, B., Sycha, T., Gustorff, B., Schmetterer, L. F., Lehr, S., Eichler, H. G., Auff, E., & Schnider, P. (2003) · Neurology · doi:10.1212/01.wnl.0000086374.92906.6a · Cited by 95
The effects of botulinum toxin A on mechanical and cold allodynia in a rat model of neuropathic pain
Park, H. J., Lee, Y., Lee, J., Park, C.-M., & Moon, D. E. (2006) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/bf03022619 · Cited by 90
Botulinum Toxin type A reduces capsaicin-evoked pain and neurogenic vasodilatation in human skin
Tugnoli, V., Capone, J. G., Eleopra, R., et al. (2006) · Pain · doi:10.1016/j.pain.2006.10.030 · Cited by 81
Understanding Neuropathic Pain
Zieglgänsberger, W., Berthele, A., & Tölle, T. R. (2005) · CNS Spectrums · doi:10.1017/s1092852900022628 · Cited by 79
Botulinum Toxin A Relieved Neuropathic Pain in a Case of Post-Herpetic Neuralgia
Liu, H.-T., Tsai, S., Kao, M., et al. (2006) · Pain Medicine · doi:10.1111/j.1526-4637.2006.00100.x · Cited by 74
Botulinum Toxin A Improved Burning Pain and Allodynia in Two Patients With Spinal Cord Pathology
Jabbari, B., Maher, N., & Difazio, M. P. (2003) · Pain Medicine · doi:10.1046/j.1526-4637.2003.03013.x · Cited by 59
Clinical value of botulinum toxin in neurological indications
Ward, A. B., Molenaers, G., Colosimo, C., & Berardelli, A. (2006) · European Journal of Neurology · doi:10.1111/j.1468-1331.2006.01650.x · Cited by 58
Botulinum toxin A does not alter capsaicin-induced pain perception in human skin
Schulte‐Mattler, W., Opatz, O. S., Blersch, W., et al. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2007.03.023 · Cited by 35
Chapter 3 Nociceptors: neurogenic inflammation
Handwerker, H. O. (2006) · Handbook of clinical neurology · doi:10.1016/s0072-9752(06)80007-2 · Cited by 11
Cited by
EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision
Attal, N., Cruccu, G., Baron, R., Haanpää, M., Hansson, P., Jensen, T. S., & Nurmikko, T. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.02999.x · Cited by 1,873
Self-citationNeuropathic pain: diagnosis, pathophysiological mechanisms, and treatment
Baron, R., Binder, A., & Wasner, G. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70143-5 · Cited by 1,816
Neuropathic Pain: From Mechanisms to Treatment
Finnerup, N. B., Kuner, R., & Jensen, T. S. (2021) · Physiological Reviews · doi:10.1152/physrev.00045.2019 · Cited by 1,558
Dworkin, R. H., O'Connor, A. B., Audette, J., Baron, R., Gourlay, G. K., Haanpää, M. L., Kent, J. L., Krane, E. J., LeBel, A. A., Levy, R. M., et al. (2010) · Mayo Clinic Proceedings · doi:10.4065/mcp.2009.0649 · Cited by 1,325
Aurora, S., Dodick, D., Turkel, C., DeGryse, R., Silberstein, S., Lipton, R., Diener, H., & Brin, M. (2010) · Cephalalgia · doi:10.1177/0333102410364676 · Cited by 1,047
Metadata
- Authors
- Ranoux, D., Attal, N., Morain, F., & Bouhassira, D.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2008-06-10
- Volume
- 64
- Issue
- 3
- Pages
- 274-283
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2019686332
- Cited by
- 459
- References
- 35
- FWCI
- 21.21
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.